1. Home
  2. OCC vs TLSA Comparison

OCC vs TLSA Comparison

Compare OCC & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

N/A

Current Price

$9.38

Market Cap

125.2M

Sector

Industrials

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$0.69

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCC
TLSA
Founded
1983
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.2M
145.1M
IPO Year
2001
2017

Fundamental Metrics

Financial Performance
Metric
OCC
TLSA
Price
$9.38
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.97
AVG Volume (30 Days)
101.1K
★ 537.6K
Earning Date
12-17-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 290.91
N/A
EPS
N/A
★ N/A
Revenue
★ $87,828,590.00
N/A
Revenue This Year
$22.52
N/A
Revenue Next Year
$18.51
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 37.03
N/A
52 Week Low
$4.02
$0.57
52 Week High
$27.98
$1.90

Technical Indicators

Market Signals
Indicator
OCC
TLSA
Relative Strength Index (RSI) 34.97 33.26
Support Level $9.27 N/A
Resistance Level $10.56 $1.21
Average True Range (ATR) 0.94 0.09
MACD -0.26 -0.03
Stochastic Oscillator 27.19 23.22

Price Performance

Historical Comparison
OCC
TLSA

About OCC Optical Cable Corporation

Optical Cable Corp manufactures a broad range of fiber optic and copper data communication cabling and connectivity solutions for the enterprise, wireless carrier, and specialty markets. The Company offers high quality products that operate as a system solution or integrate with other components, including fiber, copper, hybrid cabling, cabinets, racks, enclosures, and deployable solutions for enterprise networks, data centers, residential, campus, Passive Optical LAN installations, and customized applications in military, industrial, mining, petrochemical, renewable energy, and broadcast industries. It operates a single reportable segment covering the design, development, manufacture, and marketing of its cabling and connectivity solutions.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: